Excerpta Medica announces the launch of Clinical Therapeutics Journal Club
(CTJournalClub.com)-an innovative online resource offering the latest in
pharmaceutical progress. Medical professionals can now keep pace with
important clinical developments through the original research reports and
expert reviews provided at http://ctjournalclub.com/.
Articles accepted for publication in Excerpta Medica's well-respected
print journal Clinical Therapeutics will be considered for one of the
featured spots on the CTJournalClub.com Web site. Each article will be
accompanied by a short, insightful commentary provided by Clinical
Therapeutics Editor-in-Chief, Philip D. Walson, MD, or another member of
the Clinical Therapeutics distinguished Editorial Board.
CTJournalClub.com not only offers medical practitioners a convenient
way of remaining current, it also offers clinical investigators and
research sponsors the chance to extend the presence of their Clinical
Therapeutics article. According to Vicki Donoso, Executive
Publisher-Clinical Therapeutics, "CTJournalClub.com will provide clinical
investigators a wonderful opportunity to further highlight and expand the
reach of their clinical work in a scientifically credible forum."
About Excerpta Medica
Excerpta Medica, an Elsevier business, is a global communications
company that services global health care clients in the areas of medical
education, medical communications, and publication planning. Excerpta
Medica brings an experienced team of professionals from pharmaceuticals,
health care, and medical publishing to deliver scientific and creative
solutions. Excerpta Medica (http://www.excerptamedica.com) has offices in
the US (Bridgewater, NJ) and The Netherlands (Amsterdam).
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in over
70 offices worldwide publish more than 2,000 journals and 1,900 new books
per year, in addition to offering a suite of innovative electronic
products. Elsevier is part of Reed Elsevier Group plc, a world-leading
publisher and information provider. Reed Elsevier's ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York
Stock Exchange). For more information visit http://www.reedelsevier.com.
Excerpta Medica
http://www.excerptamedica.com
Publication Date: 2006-10-07 02:00
|
